Royal Bank of Canada
KYTH

Royal Bank of Canada’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Royal Bank of Canada’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-191,753
Closed -$14.4M – 7211
2015
Q3 		$14.4M Buy
191,753
+187,242
+4,151% +$14M 0.01% 955
2015
Q2 		$340K Sell
4,511
-33,654
-88% -$1.8M ﹤0.01% 3946
2015
Q1 		$1.91M Buy
38,165
+37,265
+4,141% +$1.56M ﹤0.01% 2316
2014
Q4 		$31K Buy
900
+600
+200% +$20.9K ﹤0.01% 5241
2014
Q3 		$10K Sell
300
-17,000
-98% -$599K ﹤0.01% 5494
2014
Q2 		$664K Buy
+17,300
New +$604K ﹤0.01% 3182
2014
Q1 		– Sell
-27,700
Closed -$1.03M – 6356
2013
Q4 		$1.03M Sell
27,700
-20,461
-42% -$849K ﹤0.01% 2801
2013
Q3 		$2.2M Sell
48,161
-26,639
-36% -$797K ﹤0.01% 2137
2013
Q2 		$2.02M Buy
+74,800
New +$1.71M ﹤0.01% 2049

Royal Bank of Canada's KYTH Position: Q4 2015 in Review

Royal Bank of Canada sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 191,753 shares — an estimated $14.4M sold.

Royal Bank of Canada first reported a position in KYTH in Q2 2013 and held it in 9 quarters. The position peaked at $14.4M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Royal Bank of Canada reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Royal Bank of Canada sold 191,753 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $14.4M.
  • Royal Bank of Canada first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 9 quarters.
  • Royal Bank of Canada's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $14.4M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Royal Bank of Canada's 13F filing for Q4 2015, filed 16 Feb 2016.